Does discontinuation of aspirin 1 to 3 months after PCI with continued P2Y12 inhibitor monotherapy reduce bleeding without increasing MACE in patients after PCI?
Discontinuing aspirin 1 to 3 months post-PCI while continuing a P2Y12 inhibitor reduces bleeding risk without increasing ischemic events.
Discontinuation of aspirin with continued P2Y12 inhibitor monotherapy reduces risk of bleeding when stopped 1 to 3 months after PCI. An increased risk of MACE was not observed after discontinuation of aspirin, including in patients with acute coronary syndrome.
O’Donoghue et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: